Biodesix, Inc.
BDSX
$0.2867
-$0.0132-4.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.19% | 39.28% | 34.54% | 50.99% | 63.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.19% | 39.28% | 34.54% | 50.99% | 63.63% |
| Cost of Revenue | 16.63% | 28.69% | 29.42% | 19.73% | 0.19% |
| Gross Profit | 22.43% | 42.44% | 36.15% | 62.71% | 97.77% |
| SG&A Expenses | -0.53% | 24.42% | 29.17% | 18.07% | 8.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.85% | 25.38% | 29.42% | 14.46% | 1.42% |
| Operating Income | 17.26% | 4.38% | -19.79% | 25.23% | 33.02% |
| Income Before Tax | 18.46% | 9.72% | 6.31% | 19.08% | 27.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.46% | 9.72% | 6.31% | 19.08% | 27.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.46% | 9.72% | 6.31% | 19.08% | 27.21% |
| EBIT | 17.26% | 4.38% | -19.79% | 25.23% | 33.02% |
| EBITDA | 20.04% | 13.15% | -11.10% | 33.37% | 38.77% |
| EPS Basic | 45.90% | 43.13% | 48.98% | 50.03% | 41.75% |
| Normalized Basic EPS | 46.04% | 43.76% | 49.01% | 51.46% | 41.97% |
| EPS Diluted | 45.90% | 43.13% | 48.98% | 50.03% | 41.75% |
| Normalized Diluted EPS | 46.04% | 43.76% | 49.01% | 51.46% | 41.97% |
| Average Basic Shares Outstanding | 50.82% | 58.79% | 83.54% | 61.99% | 24.95% |
| Average Diluted Shares Outstanding | 50.82% | 58.79% | 83.54% | 61.99% | 24.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |